Cargando…

Carbenoxolone does not cross the blood brain barrier: an HPLC study

BACKGROUND: Carbenoxolone (CBX) is a widely used gap junctional blocker. Considering several reports indicating that transient gap junctional blockade could be a favourable intervention following injuries to central nervous tissue, and some current enthusiasm in studies using systemic injections of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leshchenko, Yevgen, Likhodii, Sergei, Yue, Wendy, Burnham, William M, Perez Velazquez, Jose L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351195/ https://www.ncbi.nlm.nih.gov/pubmed/16405728 http://dx.doi.org/10.1186/1471-2202-7-3

Ejemplares similares

Hypokalaemic paralysis due to carbenoxolone.
por: Rankin, J., et al.
Publicado: (1973)

Carbenoxolone pretreatment and treatment of posttraumatic epilepsy
por: Chen, Weiguan, et al.
Publicado: (2013)

Encapsulated Carbenoxolone Reduces Lung Metastases
por: Karsch-Bluman, Adi, et al.
Publicado: (2019)

Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis
por: Teshima, Takahiro, et al.
Publicado: (2015)

The Anti-Epileptic Effects of Carbenoxolone In Vitro and In Vivo
por: Volnova, Anna, et al.
Publicado: (2022)

Carbenoxolone induced depression of rhythmogenesis in the pre-Bötzinger Complex
por: Elsen, Frank P, et al.
Publicado: (2008)

Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice
por: Hosseinzadeh, Hossein, et al.
Publicado: (2003)

Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism
por: Teshima, Takahiro, et al.
Publicado: (2016)

TAT-Gap19 and Carbenoxolone Alleviate Liver Fibrosis in Mice
por: Crespo Yanguas, Sara, et al.
Publicado: (2018)

Carbenoxolone has the potential to ameliorate acute incision pain in rats
por: Dong, Shuzhen, et al.
Publicado: (2021)

Pathway Analysis Reveals Common Pro-Survival Mechanisms of Metyrapone and Carbenoxolone after Traumatic Brain Injury
por: Hellmich, Helen L., et al.
Publicado: (2013)

Does sumatriptan cross the blood–brain barrier in animals and man?
por: Tfelt-Hansen, Peer Carsten
Publicado: (2009)

Carbenoxolone inhibits Pannexin1 channels through interactions in the first extracellular loop
por: Michalski, Kevin, et al.
Publicado: (2016)

The gap junction blocker carbenoxolone enhances propofol and sevoflurane-induced loss of consciousness☆
por: Liu, Zhigang, et al.
Publicado: (2012)

Anticonvulsant Effect of Carbenoxolone on Chronic Epileptic Rats and Its Mechanism Related to Connexin and High-Frequency Oscillations
por: Liu, Benke, et al.
Publicado: (2022)

Decreased Fast Ripples in the Hippocampus of Rats with Spontaneous Recurrent Seizures Treated with Carbenoxolone and Quinine
por: Ventura-Mejía, Consuelo, et al.
Publicado: (2014)

Carbenoxolone-sensitive and cesium-permeable potassium channel in the rod cells of frog taste discs
por: Okada, Yukio, et al.
Publicado: (2015)

Carbenoxolon Is Capable to Regulate the Mitochondrial Permeability Transition Pore Opening in Chronic Alcohol Intoxication
por: Baburina, Yulia, et al.
Publicado: (2021)

A Novel Approach to Reducing Lung Metastasis in Osteosarcoma: Increasing Cell Stiffness with Carbenoxolone
por: Kita, Kouji, et al.
Publicado: (2023)

Carbenoxolone Blocks the Light-Evoked Rise in Intracellular Calcium in Isolated Melanopsin Ganglion Cell Photoreceptors
por: Bramley, Jayne R., et al.
Publicado: (2011)

Carbenoxolone-mediated cytotoxicity inhibits Vaccinia virus replication in a human keratinocyte cell line
por: Haga, Ismar R., et al.
Publicado: (2018)

Characteristics of compounds that cross the blood-brain barrier
por: Banks, William A
Publicado: (2009)

The Final Frontier – Crossing the Blood-brain Barrier
por: Sly, William S, et al.
Publicado: (2013)

Astrocytic gap junction inhibition by carbenoxolone enhances the protective effects of ischemic preconditioning following cerebral ischemia
por: Ma, Di, et al.
Publicado: (2018)

Predicting the Blood-Brain Barrier Permeability of New Drug-Like Compounds via HPLC with Various Stationary Phases
por: Janicka, Małgorzata, et al.
Publicado: (2020)

Carbenoxolone inhibits TRPV4 channel‐initiated oxidative urothelial injury and ameliorates cyclophosphamide‐induced bladder dysfunction
por: Zhang, Xiling, et al.
Publicado: (2017)

Carbenoxolone decreases monocrotaline-induced pulmonary inflammation and pulmonary arteriolar remodeling in rats by decreasing the expression of connexins in T lymphocytes
por: Zhang, Liang, et al.
Publicado: (2020)

Carbenoxolone inhibits mechanical stress-induced osteogenic differentiation of mesenchymal stem cells by regulating p38 MAPK phosphorylation
por: Li, Shenglong, et al.
Publicado: (2018)

Possible strategies to cross the blood–brain barrier
por: Bellettato, Cinzia M., et al.
Publicado: (2018)

The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier
por: Chiu, Chi-Fen, et al.
Publicado: (2020)

Baseline urinary KIM-1 concentration in detecting acute kidney injury should be interpreted with patient pre-existing nephropathy
por: Huang, Yun, et al.
Publicado: (2019)

Carbenoxolone induces apoptosis and inhibits survivin and survivin-ΔEx3 genes expression in human leukemia K562 cells
por: Moosavi, M.A, et al.
Publicado: (2011)

TAT-Modified ω-Conotoxin MVIIA for Crossing the Blood-Brain Barrier
por: Yu, Shuo, et al.
Publicado: (2019)

Locked Out: Phoenixin-14 Does Not Cross a Stem-Cell-Derived Blood–Brain Barrier Model
por: Schalla, Martha A., et al.
Publicado: (2023)

Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease
por: Banks, William A
Publicado: (2008)

Efficacy of Pembrolizumab and Nivolumab in Crossing the Blood Brain Barrier
por: Abid, Haisam, et al.
Publicado: (2019)

Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles
por: Saint-Pol, Julien, et al.
Publicado: (2020)

Chemotactic synthetic vesicles: Design and applications in blood-brain barrier crossing
por: Joseph, Adrian, et al.
Publicado: (2017)

Carbenoxolone Treatment Ameliorated Metabolic Syndrome in WNIN/Ob Obese Rats, but Induced Severe Fat Loss and Glucose Intolerance in Lean Rats
por: Prasad Sakamuri, Siva Sankara Vara, et al.
Publicado: (2012)

A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma
por: Salcher, Stefan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_il93hph1qhrgh56vjt2ue5044q